AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23294420 — intervention group
Group type: EXPERIMENTAL
Intervention: 5400 m altitude - females
Number of subjects: 37
Study 21401764 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurse intervention group
Number of subjects: 230
Study 21401764 — intervention group
Group type: COMPARATOR
Intervention: General practitioner control group
Number of subjects: 230
Study 21401764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 230
Study 18416823 — intervention group
Group type: EXPERIMENTAL
Intervention: RAISIN (1 cup raisins/d)
Number of subjects: 34
Study 18416823 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK (increased steps walked/d)
Number of subjects: 34
Study 18416823 — intervention group
Group type: EXPERIMENTAL
Intervention: RAISINS + WALK (combination of both interventions)
Number of subjects: 34
Study 17041169 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 153
Study 17041169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 15581120 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load condition
Number of subjects: 0
Study 15581120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load condition
Number of subjects: 0
Study 15581120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load condition preceded by high-load trial
Number of subjects: 0
Study 15581120 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load and low-load conditions mixed
Number of subjects: 0
Study 11084177 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic norgestimate-ethinyl E2
Number of subjects: 201
Study 11084177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201
Study 9487836 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% sodium bicarbonate dentifrice, 1.5% hydrogen peroxide solution, mouth moisturizer
Number of subjects: 150
Study 9487836 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest dentifrice, Toothette Plus with hydrogen peroxide solution, mouth moisturizer
Number of subjects: 150
Study 9487836 — intervention group
Group type: COMPARATOR
Intervention: Crest dentifrice, Toothette Plus with control solution, no mouth moisturizer
Number of subjects: 150
Study 9487836 — intervention group
Group type: COMPARATOR
Intervention: Crest dentifrice, Toothette without baking soda, control solution, no mouth moisturizer
Number of subjects: 150
Study 9487836 — intervention group
Group type: EXPERIMENTAL
Intervention: Crest dentifrice, Toothette saturated with 1.5% flavored H2O2, no mouth moisturizer
Number of subjects: 150
Study 8376833 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine
Number of subjects: 0
Study 8376833 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0
Study 8376833 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3019910 — intervention group
Group type: EXPERIMENTAL
Intervention: Nylon waist cord worn throughout the follow-up period
Number of subjects: 40
Study 3019910 — intervention group
Group type: COMPARATOR
Intervention: Subjects who cut off the cord
Number of subjects: 40
Study 30407961 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based AACT training for postpartum nurses
Number of subjects: 70
Study 30407961 — intervention group
Group type: COMPARATOR
Intervention: Simulation-based I-PASS education for control group
Number of subjects: 70
Study 30407961 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based AACT training for labor and delivery nurses
Number of subjects: 70
Study 27649413 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception training with duration-equalized English vowels
Number of subjects: 34
Study 27649413 — intervention group
Group type: COMPARATOR
Intervention: Watching English videos (Control)
Number of subjects: 34
Study 24886787 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG surgery (n=1472)
Number of subjects: 2932
Study 24886787 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG surgery (n=1460)
Number of subjects: 2932
Study 21798891 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 4853
Study 21798891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4853
Study 20683611 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training (4 × 20 s contractions at 80% of maximum voluntary plantarflexion moment, three times per week for 8 weeks)
Number of subjects: 12
Study 20683611 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric training
Number of subjects: 12
Study 20683611 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in TST K
Number of subjects: 12
Study 19071991 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective priming of naming responses without stimulus repetition
Number of subjects: 0
Study 19071991 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective priming of naming responses with varying number of stimulus presentations
Number of subjects: 0
Study 16161944 — intervention group
Group type: COMPARATOR
Intervention: Statin treatment
Number of subjects: 112
Study 16161944 — intervention group
Group type: COMPARATOR
Intervention: Statin-naive patients
Number of subjects: 112
Study 12748132 — intervention group
Group type: EXPERIMENTAL
Intervention: Single subacromial injection of methylprednisolone with bupivicaine (group S, n=54)
Number of subjects: 98
Study 12748132 — intervention group
Group type: COMPARATOR
Intervention: Bupivicaine only (group C, n=44)
Number of subjects: 98
Study 11076414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pumpan (homeopathic compound)
Number of subjects: 49
Study 11076414 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 49
Study 8641404 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG‐CSF primed PBSCT
Number of subjects: 17
Study 8641404 — intervention group
Group type: COMPARATOR
Intervention: Autologous bone marrow transplantation (ABMT)
Number of subjects: 17
Study 8641404 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG‐CSF mobilized PBSCT
Number of subjects: 17
Study 8641404 — intervention group
Group type: EXPERIMENTAL
Intervention: PBSCT mobilized solely using rhG‐CSF
Number of subjects: 17
Study 2071888 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 10 mg doses of vinpocetine
Number of subjects: 203
Study 2071888 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 20 mg doses of vinpocetine
Number of subjects: 203
Study 2071888 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study 6827767 — intervention group
Group type: EXPERIMENTAL
Intervention: Night urinary sodium excretion estimated by quantitative chloride titrator strips
Number of subjects: 3
Study 6827767 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative chloride titrator applied every other day
Number of subjects: 3
Study 6827767 — intervention group
Group type: EXPERIMENTAL
Intervention: Three 24-hour urine collections
Number of subjects: 3
Study 31427345 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous sumatriptan injection
Number of subjects: 136
Study 31427345 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 136
Study 29615090 — intervention group
Group type: EXPERIMENTAL
Intervention: InSciEd Out program - school-based anti-stigma intervention in mental health
Number of subjects: 0
Study 29615090 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher narratives
Number of subjects: 0
Study 27821083 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Internal Radiation Therapy (SIRT) using yttrium‐90 resin microspheres (SIR‐Spheres®)
Number of subjects: 360
Study 27821083 — intervention group
Group type: COMPARATOR
Intervention: Continuous oral Sorafenib (Nexavar®) at a dose of 400 mg twice daily
Number of subjects: 360
Study 27821083 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Internal Radiation Therapy (SIRT)
Number of subjects: 360
Study 27821083 — intervention group
Group type: COMPARATOR
Intervention: Continuous oral Sorafenib (Nexavar®)
Number of subjects: 360
Study 24786605 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes history (n=62)
Number of subjects: 504
Study 24786605 — intervention group
Group type: COMPARATOR
Intervention: No diabetes history (n=442)
Number of subjects: 504
Study 22678846 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D TOF-MRA at 3T
Number of subjects: 96
Study 22678846 — intervention group
Group type: COMPARATOR
Intervention: 3D TOF-MRA at 1.5T
Number of subjects: 96
Study 22678846 — intervention group
Group type: COMPARATOR
Intervention: DSA (reference standard)
Number of subjects: 96
Study 19217229 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (0.125-2mg/d) for 6 months
Number of subjects: 12
Study 18591574 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole (mean dose approximately 9 mg/day at endpoint; range = 0.7‐15.0 mg)
Number of subjects: 256
Study 18591574 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 256
Study 18591574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study 15836940 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthosis applied to the case group
Number of subjects: 29
Study 15836940 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 29
Study 15836940 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (correlation analysis)
Number of subjects: 29
Study 12027240 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths model of case management (SCM)
Number of subjects: 77
Study 12027240 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 77
Study 8771941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole 500 mg (original manufacturer)
Number of subjects: 399
Study 8771941 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole 500 mg (locally produced)
Number of subjects: 399
Study 8771941 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg
Number of subjects: 399
Study 1729865 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright cycle ergometry
Number of subjects: 14
Study 1729865 — intervention group
Group type: COMPARATOR
Intervention: Recumbent cycle ergometry
Number of subjects: 14
Study 6418371 — intervention group
Group type: EXPERIMENTAL
Intervention: FA plus methyl‐CCNU (FAMe)
Number of subjects: 241
Study 6418371 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil plus Adriamycin (FA)
Number of subjects: 241
Study 6418371 — intervention group
Group type: COMPARATOR
Intervention: FA plus mitomycin C (FAMi)
Number of subjects: 241
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramphenicol
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 144
Study 30428828 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (MIC test)
Number of subjects: 144
Study 24924603 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxoprofen sodium hydrogel patch (LX‐P)
Number of subjects: 169
Study 24924603 — intervention group
Group type: COMPARATOR
Intervention: Loxoprofen sodium tablet (LX‐T)
Number of subjects: 169
Study 25201893 — intervention group
Group type: EXPERIMENTAL
Intervention: OMNIHEART-like nutrient profile
Number of subjects: 2195
Study 25201893 — intervention group
Group type: COMPARATOR
Intervention: Control (typical American nutrient profile)
Number of subjects: 2195
Study 25201893 — intervention group
Group type: EXPERIMENTAL
Intervention: OMNIHEART score higher by 1 point
Number of subjects: 2195
Study 22292152 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) membrane
Number of subjects: 0
Study 22292152 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 0
Study 20628238 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab treatment for 1 year
Number of subjects: 186
Study 18954518 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral turbinoplasty combined with septoplasty
Number of subjects: 12
Study 18954518 — intervention group
Group type: COMPARATOR
Intervention: No surgery on the inferior turbinates
Number of subjects: 12
Study 16151760 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg IV infused eletriptan
Number of subjects: 45
Study 16151760 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg SC sumatriptan
Number of subjects: 45
Study 16151760 — intervention group
Group type: COMPARATOR
Intervention: SC placebo
Number of subjects: 45
Study 11980385 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca-Cola
Number of subjects: 10
Study 11980385 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 11916912 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes patients
Number of subjects: 0
Study 11916912 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 9816521 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta radiation (12, 14 or 16 Gy delivered with a 5 F non‐centered catheter)
Number of subjects: 35
Study 9816521 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta radiation (12, 14 or 16 Gy)
Number of subjects: 35
Study 7654506 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopentin (50 mg s.c. every other day for 4 weeks post-splenectomy)
Number of subjects: 28
Study 7654506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no thymopentin treatment)
Number of subjects: 28
Study 7654506 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymopentin
Number of subjects: 28
Study 7654506 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 2199642 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1.0 mg/kg/day for 3 days, then progressively decreased for 12 days)
Number of subjects: 57
Study 2199642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 342624 — intervention group
Group type: COMPARATOR
Intervention: Inactivated influenza virus vaccines containing 200 or 400 chicken cell‐agglutinating units of both A/New Jersey/76 and A/Victoria/75 antigens
Number of subjects: 0
Study 342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole‐virus vaccines
Number of subjects: 0
Study 342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvirion vaccines
Number of subjects: 0
Study 342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of vaccines
Number of subjects: 0
Study 342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination
Number of subjects: 0
Study 342624 — intervention group
Group type: EXPERIMENTAL
Intervention: Later revaccinations due to low titers of A/Victoria antibody
Number of subjects: 0
Study 6752800 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy for chronic cases of aphakic cystoid macular edema
Number of subjects: 0
Study 6752800 — intervention group
Group type: EXPERIMENTAL
Intervention: Photocoagulation therapies
Number of subjects: 0
Study 6752800 — intervention group
Group type: COMPARATOR
Intervention: Nonrandomized, uncontrolled trials
Number of subjects: 0
Study 6752800 — intervention group
Group type: COMPARATOR
Intervention: Randomized, controlled clinical studies
Number of subjects: 0
Study 29096225 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat-based Pilates training (60-min sessions, twice a week for 16 weeks)
Number of subjects: 61
Study 27502478 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of vitamin A intake
Number of subjects: 848
Study 27502478 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest quartile of vitamin A intake among participants with CFHY402H
Number of subjects: 848
Study 27502478 — intervention group
Group type: EXPERIMENTAL
Intervention: Second highest quartile of vitamin A intake among participants with CFHY402H
Number of subjects: 848
Study 24014392 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning with postconditioning (RIPC with RIPostC)
Number of subjects: 1280
Study 24014392 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1280
Study 24014392 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning with postconditioning (RIPC with RIPostC) in off-pump coronary artery bypass surgery subgroup
Number of subjects: 1280
Study 23136160 — intervention group
Group type: EXPERIMENTAL
Intervention: 32°C
Number of subjects: 36
Study 23136160 — intervention group
Group type: COMPARATOR
Intervention: 34°C
Number of subjects: 36
Study 20562430 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNB-1b 50 microg
Number of subjects: 372
Study 20562430 — intervention group
Group type: EXPERIMENTAL
Intervention: IFNB-1b 250 microg
Number of subjects: 372
Study 20562430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 18065407 — intervention group
Group type: EXPERIMENTAL
Intervention: high CHOEP (cyclophosphamide 1400 mg/m2, doxorubicin 65 mg/m2, vincristine 2 mg, etoposide 175 mg/m2 x3, prednisone 100 mg x5)
Number of subjects: 389
Study 18065407 — intervention group
Group type: COMPARATOR
Intervention: CHOEP-21
Number of subjects: 389
Study 18065407 — intervention group
Group type: EXPERIMENTAL
Intervention: high CHOEP
Number of subjects: 389
Study 15809558 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% VO2 reserve (LO)
Number of subjects: 13
Study 15809558 — intervention group
Group type: EXPERIMENTAL
Intervention: 80% VO2 reserve (HI)
Number of subjects: 13
Study 12887555 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal stimulation with 'Mommy and I are one'
Number of subjects: 62
Study 12887555 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimulus 'People are walking'
Number of subjects: 62
Study 12887555 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentially shame-inducing stimulus 'I am completely isolated'
Number of subjects: 62
Study 10229306 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-testing for postprandial glycosuria
Number of subjects: 6198
Study 8686481 — intervention group
Group type: EXPERIMENTAL
Intervention: Zuclopenthixol and clonazepam
Number of subjects: 28
Study 8686481 — intervention group
Group type: COMPARATOR
Intervention: Lithium and clonazepam
Number of subjects: 28
Study 2058571 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% of calories from carbohydrate)
Number of subjects: 8
Study 2058571 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet (60% of calories from fat)
Number of subjects: 8
Study 2058571 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed diet (45% of calories from fat)
Number of subjects: 8
Study 6661892 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen 250 mg/day
Number of subjects: 47
Study 6661892 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen 150 mg/day
Number of subjects: 47
Study 29749805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion (NAH w|lac)
Number of subjects: 13
Study 29749805 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (NAH w|placebo)
Number of subjects: 13
Study 29749805 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lactate infusion (IAH w|lac)
Number of subjects: 13
Study 29924160 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing interventions based on Imogene King's Theory of Goal Attainment
Number of subjects: 60
Study 29924160 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 27569177 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance therapy (8-week, 3-times-per-week programme)
Number of subjects: 67
Study 27569177 — intervention group
Group type: COMPARATOR
Intervention: Standard care (usual activities and medication)
Number of subjects: 67
Study 22704138 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin 3000 mg/day
Number of subjects: 186
Study 22704138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized controlled trials reporting adverse event outcomes
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Harm reporting criteria satisfaction
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies addressing harm in various sections
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Specification of adverse events evaluated
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of harm information collection
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution of harm to intervention
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for patient withdrawal
Number of subjects: 152
Study 20299044 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting severity of adverse events
Number of subjects: 152
Study 18036362 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 22275
Study 18036362 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo or no treatment)
Number of subjects: 22275
Study 15606434 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerodose Inhaler
Number of subjects: 22
Study 12030732 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg t.i.d. for 12 weeks
Number of subjects: 18
Study 12030732 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy nonsmokers)
Number of subjects: 18
Study 10492107 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 17beta‐oestradiol/oestriol (Trisequens) with norethisterone acetate
Number of subjects: 58
Study 10492107 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐oestradiol (Estrapak) with norethisterone acetate
Number of subjects: 58
Study 8684407 — intervention group
Group type: EXPERIMENTAL
Intervention: Terazosin (10 mg daily)
Number of subjects: 1229